Cleared Traditional

K781819 - POST EXTRA SYSTOLIC POTENTIATOR

K781819 is the FDA 510(k) clearance for POST EXTRA SYSTOLIC POTENTIATOR by Medrad, Inc.. It is a Class 2 Cardiovascular device (product code DQO) cleared through the Traditional 510(k) pathway after a 80-day FDA review.

K781819 · Medrad, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1979
Decision
80d
Days
Class 2
Risk

K781819 is an FDA 510(k) clearance for the POST EXTRA SYSTOLIC POTENTIATOR. Classified as Catheter, Intravascular, Diagnostic (product code DQO), Class II - Special Controls.

Submitted by Medrad, Inc. (Mchenry, US). The FDA issued a Cleared decision on January 15, 1979 after a review of 80 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1200 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medrad, Inc. devices

Submission Details

510(k) Number K781819 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 27, 1978
Decision Date January 15, 1979
Days to Decision 80 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
45d faster than avg
Panel avg: 125d · This submission: 80d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQO Catheter, Intravascular, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQO Catheter, Intravascular, Diagnostic

All 294
Devices cleared under the same product code (DQO) and FDA review panel - the closest regulatory comparables to K781819.
CENTRAL VEIN CATHETERIZATION KIT
K800741 · Medical Components, Inc. · Apr 1980
CENTRAL VENOUS PRESSURE CATHETER
K800461 · Medical Components, Inc. · Mar 1980
WHITE SEALING CAP
K791915 · Quinton, Inc. · Dec 1979
CATHETER, DIGITAL POSITRAL II
K782082 · C.R. Bard, Inc. · Dec 1978
PRESSURE MONITORING INJECTION LINES
K781558 · Cobe Laboratories, Inc. · Oct 1978
MYOCATH KIT
K780529 · Sorensen Research · May 1978